Wacker Chemie Valuation

Is WKCM.F undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

4/6

Valuation Score 4/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of WKCM.F when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: WKCM.F ($72.55) is trading below our estimate of fair value ($188.39)

Significantly Below Fair Value: WKCM.F is trading below fair value by more than 20%.


Key Valuation Metric

Which metric is best to use when looking at relative valuation for WKCM.F?

Key metric: As WKCM.F is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for WKCM.F. This is calculated by dividing WKCM.F's market cap by their current earnings.
What is WKCM.F's PE Ratio?
PE Ratio28x
Earnings€124.30m
Market Cap€3.48b

Price to Earnings Ratio vs Peers

How does WKCM.F's PE Ratio compare to its peers?

The above table shows the PE ratio for WKCM.F vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average27.4x
ASH Ashland
18.5x5.0%US$3.7b
FUL H.B. Fuller
22.8x14.1%US$4.2b
AVNT Avient
31.4x20.4%US$4.8b
SXT Sensient Technologies
36.8x20.2%US$3.3b
WKCM.F Wacker Chemie
28x37.0%US$3.5b

Price-To-Earnings vs Peers: WKCM.F is expensive based on its Price-To-Earnings Ratio (28x) compared to the peer average (27.4x).


Price to Earnings Ratio vs Industry

How does WKCM.F's PE Ratio compare vs other companies in the US Chemicals Industry?

7 CompaniesPrice / EarningsEstimated GrowthMarket Cap
FFHL Fuwei Films (Holdings)
2.8xn/aUS$27.11m
BSLK Bolt Projects Holdings
0.06xn/aUS$10.03m
BON Bon Natural Life
3xn/aUS$7.46m
GSPI Green Star Products
1.7xn/aUS$1.49m
WKCM.F 28.0xIndustry Avg. 22.7xNo. of Companies8PE01224364860+
7 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: WKCM.F is expensive based on its Price-To-Earnings Ratio (28x) compared to the US Chemicals industry average (22.9x).


Price to Earnings Ratio vs Fair Ratio

What is WKCM.F's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

WKCM.F PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio28x
Fair PE Ratio33.4x

Price-To-Earnings vs Fair Ratio: WKCM.F is good value based on its Price-To-Earnings Ratio (28x) compared to the estimated Fair Price-To-Earnings Ratio (33.4x).


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst WKCM.F forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentUS$72.55
US$119.85
+65.2%
12.5%US$141.44US$91.15n/a15
Nov ’25US$84.33
US$129.37
+53.4%
17.6%US$193.31US$94.48n/a16
Oct ’25US$97.95
US$138.94
+41.9%
14.6%US$198.71US$109.40n/a15
Sep ’25US$94.34
US$138.40
+46.7%
13.5%US$194.28US$109.15n/a15
Aug ’25US$101.50
US$138.23
+36.2%
14.2%US$192.43US$108.11n/a15
Jul ’25US$111.33
US$137.26
+23.3%
13.8%US$190.68US$110.34n/a15
Jun ’25n/a
US$135.86
0%
14.3%US$190.42US$110.18n/a15
May ’25US$110.30
US$135.86
+23.2%
14.3%US$190.42US$110.18n/a15
Apr ’25US$113.25
US$131.83
+16.4%
15.2%US$191.19US$102.04n/a15
Mar ’25US$110.98
US$132.78
+19.6%
15.3%US$192.79US$108.31n/a15
Feb ’25US$110.51
US$132.78
+20.2%
15.3%US$192.79US$108.31n/a15
Jan ’25US$125.00
US$152.71
+22.2%
14.3%US$195.84US$118.82n/a15
Dec ’24US$118.70
US$156.92
+32.2%
13.4%US$193.08US$117.15n/a15
Nov ’24US$118.82
US$154.21
+29.8%
14.0%US$188.38US$117.47US$84.3314
Oct ’24US$140.15
US$163.05
+16.3%
13.4%US$199.81US$118.60US$97.9515
Sep ’24US$150.17
US$165.35
+10.1%
13.0%US$202.01US$119.91US$94.3416
Aug ’24US$154.12
US$168.81
+9.5%
13.0%US$206.15US$125.68US$101.5016
Jul ’24US$137.30
US$171.69
+25.0%
14.0%US$210.22US$124.17US$111.3316
Jun ’24US$132.00
US$173.53
+31.5%
14.1%US$216.71US$122.30n/a16
May ’24US$152.50
US$183.14
+20.1%
13.7%US$222.59US$125.62US$110.3015
Apr ’24US$160.25
US$178.88
+11.6%
14.0%US$218.99US$123.59US$113.2516
Mar ’24US$157.63
US$169.70
+7.7%
17.6%US$214.16US$110.26US$110.9816
Feb ’24US$157.00
US$169.55
+8.0%
16.6%US$201.31US$113.17US$110.5116
Jan ’24US$126.00
US$164.70
+30.7%
19.3%US$223.14US$110.51US$125.0016
Dec ’23US$126.90
US$150.36
+18.5%
20.9%US$210.51US$104.25US$118.7016
Nov ’23US$115.65
US$148.53
+28.4%
21.1%US$207.43US$102.73US$118.8216

Analyst Forecast: Target price is more than 20% higher than the current share price and analysts are within a statistically confident range of agreement.


Discover undervalued companies